Literature DB >> 2846533

Mechanism of inhibition of herpes simplex virus (HSV) ribonucleotide reductase by a nonapeptide corresponding to the carboxyl terminus of its subunit 2. Specific binding of a photoaffinity analog, [4'- azido-Phe6] HSV H2-6(6-15), to subunit 1.

H Paradis1, P Gaudreau, P Brazeau, Y Langelier.   

Abstract

Herpes simplex virus (HSV) ribonucleotide reductase activity is specifically inhibited by a synthetic peptide, Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu (HSV H2-(7-15], corresponding to the carboxyl terminus of its subunit 2 (H2). In order to elucidate the mechanism of action of the nonapeptide a photoreactive analog, [4'-azido-Phe6]HSV H2-(6-15), was synthesized. The photoaffinity probe inhibits HSV ribonucleotide reductase activity, and when radioiodinated, it specifically labeled three viral proteins of 144, 95, and 85 kDa. We demonstrated by immunoprecipitation of the 144- and 95-kDa photolabeled proteins with antibodies specific to subunit 1 (H1) of HSV ribonucleotide reductase that the nonapeptide interacts with H1 and probably with its degradation products. Moreover, we obtained evidence that this specific binding is directly responsible for the ribonucleotide reductase inhibition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846533

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Production of the R2 subunit of ribonucleotide reductase from herpes simplex virus with prokaryotic and eukaryotic expression systems: higher activity of R2 produced by eukaryotic cells related to higher iron-binding capacity.

Authors:  N Lamarche; G Matton; B Massie; M Fontecave; M Atta; F Dumas; P Gaudreau; Y Langelier
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

2.  Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.

Authors:  C R Brandt; B Spencer; P Imesch; M Garneau; R Déziel
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.

Authors:  A M Bonneau; P Kibler; P White; C Bousquet; N Dansereau; M G Cordingley
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Characterization of heterosubunit complexes formed by the R1 and R2 subunits of herpes simplex virus 1 and equine herpes virus 4 ribonucleotide reductase.

Authors:  Y Sun; J Conner
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

5.  Herpes simplex virus-encoded ribonucleotide reductase: evidence for the dissociation/reassociation of the holoenzyme.

Authors:  A J Darling; E M McKay; R Ingemarson; B Booth
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

6.  Herpes simplex virus ribonucleotide reductase: expression in Escherichia coli and purification to homogeneity of a tyrosyl free radical-containing, enzymatically active form of the 38-kilodalton subunit.

Authors:  R Ingemarson; A Gräslund; A Darling; L Thelander
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly.

Authors:  Hai Xu; Catherine Faber; Tomoaki Uchiki; Joseph Racca; Chris Dealwis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

8.  Inhibition of herpes simplex virus type 1 DNA polymerase activity by peptides from the UL42 accessory protein is largely nonspecific.

Authors:  A M Owsianka; G Hart; M Murphy; J Gottlieb; R Boehme; M Challberg; H S Marsden
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy.

Authors:  H Rubin; J S Salem; L S Li; F D Yang; S Mama; Z M Wang; A Fisher; C S Hamann; B S Cooperman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

10.  Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.

Authors:  J Duan; M Liuzzi; W Paris; M Lambert; C Lawetz; N Moss; J Jaramillo; J Gauthier; R Déziel; M G Cordingley
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.